TQB2101

· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQB2101, covering 2025-04-29 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies [Phase 1]